Aclarion Publishes Cost-Effectiveness Analysis of Nociscan

Aclarion Inc. (Nasdaq: ACON, ACONW) has published a peer-reviewed article in Clinicoeconomics and Outcomes Research, titled “The Comparison of Cost-Effectiveness Between Magnetic Resonance Spectroscopy and Provocative Discography in the Identification of Chronic Low Back Pain Surgery Candidates.” The independent cost-effectiveness analysis concludes that Nociscan is effective and less costly compared to provocative discography. The findings…

This Article Is Locked, But Not Out of Reach

Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.

Create My Free Account

Curious how it works? Watch the Quickstart

Want everything unlocked? See Paid Options

Already a member? Log in here